IMR Press / FBL / Volume 3 / Issue 4 / DOI: 10.2741/A310

Frontiers in Bioscience-Landmark (FBL) is published by IMR Press from Volume 26 Issue 5 (2021). Previous articles were published by another publisher on a subscription basis, and they are hosted by IMR Press on imrpress.com as a courtesy and upon agreement with Frontiers in Bioscience.

Article
CD44 expression and growth factors
Show Less
1 Division of Cell Biology, Cancer Institute, Hokkaido University School of Medicine, Sapporo, Japan
2 Department of Neurosurgery, Hokkaido University School of Medicine, Sapporo, Japan
3 Laboratory of Molecular Neuro-Oncology, Neurosurgery Department and Winship Cancer Center, Emory University, Atlanta, Georgia, 30322, U.S.A. and Laboratory of Tumor Biology and Genetics, Neurosurgery Department, University Hospital, 1011 Lausanne, Switzerland
Front. Biosci. (Landmark Ed) 1998, 3(4), 657–664; https://doi.org/10.2741/A310
Published: 1 July 1998
Abstract

Soluble factors such as growth factors and cytokines present in the tumor microenvironment regulate a variety of genes associated with malignant properties of tumor cells such as growth, migration, invasion, and metastatic capacities. CD44 is a multi-functional adhesion molecule involved in cell to cell and cell to extracellular matrix interaction, the trapping of growth factors and cytokines, and the regulation of cell traffic. Growth factors and cytokines modify the expression, selective isoform splicing and functions of CD44, resulting in changes in the biological properties of the cells. These include adhesion of circulating tumor cells to endothelium and body cavities, and survival in response to growth factors presented by the CD44 molecule. The modification of CD44 on both tumor and host cells by growth factors may play an important role in tumor progression.

Share
Back to top